Regado Biosciences (RGDO) Misses Q2 EPS by 12c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Cowen Downgrades Regado Biosciences (RGDO) to Market Perform
August 13, 2014 6:39 AM EDTCowen downgraded Regado Biosciences (NASDAQ: RGDO) from Outperform to Market Perform and removed its price target (prior $14.00).
For an analyst ratings summary and ratings history on Regado Biosciences click here. For more ratings news on Regado Biosciences click here.
Shares of Regado Biosciences closed at $2.80 yesterday.
... More